Ruiz de Porras, V.; Bystrup, S.; Cabrero-de las Heras, S.; Musulén, E.; Palomero, L.; Alonso, M.H.; Nieto, R.; Arango, D.; Moreno, V.; Queralt, C.;
et al. Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. Cancers 2019, 11, 1540.
https://doi.org/10.3390/cancers11101540
AMA Style
Ruiz de Porras V, Bystrup S, Cabrero-de las Heras S, Musulén E, Palomero L, Alonso MH, Nieto R, Arango D, Moreno V, Queralt C,
et al. Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. Cancers. 2019; 11(10):1540.
https://doi.org/10.3390/cancers11101540
Chicago/Turabian Style
Ruiz de Porras, Vicenç, Sara Bystrup, Sara Cabrero-de las Heras, Eva Musulén, Luis Palomero, Maria Henar Alonso, Rocio Nieto, Diego Arango, Víctor Moreno, Cristina Queralt,
and et al. 2019. "Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients" Cancers 11, no. 10: 1540.
https://doi.org/10.3390/cancers11101540
APA Style
Ruiz de Porras, V., Bystrup, S., Cabrero-de las Heras, S., Musulén, E., Palomero, L., Alonso, M. H., Nieto, R., Arango, D., Moreno, V., Queralt, C., Manzano, J. L., Layos, L., Bugés, C., & Martinez-Balibrea, E.
(2019). Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. Cancers, 11(10), 1540.
https://doi.org/10.3390/cancers11101540